Generics - Generics, Cardio-vascular


Current filters:


Popular Filters

1 to 25 of 63 results

European Generic Medicines Association speaks out against EC’s perindopril decision

European Generic Medicines Association speaks out against EC’s perindopril decision


The European Generic Medicines Association (EGA) has expressed concerns over the European Commission’s…


Mylan launches generic Micardis in USA

Mylan launches generic Micardis in USA


US generic drugmaker Mylan has launched Telmisartan Tablets USP, 20mg, 40mg and 80mg, the generic version…

Boehringer IngelheimCardio-vascularGenericsMarkets & MarketingMicardisMylanRegulationTelmisartanUSA

ScinoPharm and Lee's Pharma jointly develop drugs for the Chinese market


Taiwan API specialist ScinoPharm Taiwan and Lee's Pharmaceutical Holdings have entered into two collaborations…

Bimatoprost Ophthalmic Solution 0.03% for GlaCardio-vascularChinafondaparinuxGenericsLee's PharmaceuticalMarkets & MarketingOphthalmicsProductionScinoPharmTravoprost

Actavis debuts generic copy of Catapres-TTS

Actavis debuts generic copy of Catapres-TTS


Ireland-headquartered generics major Actavis has launched a generic version of German family-owned pharma…

ActavisBoehringer IngelheimCardio-vascularCatapres-TTSGenericsMarkets & MarketingUSA

Teva launches first generic Lovaza in USA

Teva launches first generic Lovaza in USA


Israel-based Teva Pharmaceutical Industries says it has received US Food and Drug Administration approval…

Cardio-vascularGenericsGlaxoSmithKlineLovazaMarkets & MarketingRegulationTeva Pharmaceutical IndustriesUSA

Lupin launches generic Niaspan in USA


Indian drugmaker Lupin says that its US subsidiary has launched its niacin extended-release tablets USP,…

AbbVieCardio-vascularGenericsLupinMarkets & MarketingNiaspanNorth AmericaUSA

Actavis challenges Multaq and Colcrys patents


Ireland-headquartered generic drugmaker Actavis revealed on Friday (February 28) that French pharma giant…

ActavisAnti-Arthritics/RheumaticsCardio-vascularColcrysGenericsLegalMultaqNorth AmericaPatents & Trade marksRegulationSanofiTakeda PharmaceuticalsUSA

Nissan Chemical and Kowa to sue generic drugmakers over Livalo patent infringements


With the commencement this year of manufacturing and selling generic copies of the hypercholesterolemia…

Asia-PacificCardio-vascularGenericsKowaLegalLivaloNissan ChemicalPatents

Forest Labs settles Bystolic litigation with Actavis


US drugmaker Forest Laboratories has entered into a settlement agreement with generics drug major Actavis…

ActavisBystolicCardio-vascularForest LaboratoriesGenericsLegalNorth AmericaPatents

US Appeals Court reverses 2012 decision on Lovaza, clearing way for generics


Reversing a district court decision last year (The Pharma Letter May 30, 2012), the US Court of Appeals…

AmarinCardio-vascularGenericsGlaxoSmithKlineLegalLovazaNorth AmericaPar PharmaceuticalsPatentsPharmaceuticalTeva Pharmaceutical IndustriesVascepa

Ireland's HSE announces preferred ACE inhibitor and ARBs


Ireland Health Service Executive's (HSE) Medicines Management Program (MMP) has identified two new preferred…


Forest agrees another license deal for Bystolic


US drugmaker Forest Laboratories (NYSE:FRX) and Forest Laboratories Holdings have reached a settlement…

Amerigen PharmaceuticalsBystolicCardio-vascularForest LaboratoriesGenericsLicensingNorth AmericaPharmaceutical

Generic versions of Trilipix debut in USA; Mylan sued by UCB


Impax Laboratories (Nasdaq: IPXL) today announced yesterday (July 15) that it is commencing shipment…

AbbVieCardio-vascularGenericsImpax LaboratoriesLegalMarkets & MarketingMylan LaboratoriesNeurologicalNorth AmericaPatentsTripilixUCBVimpat

Statin drugs save health care systems money as well as saving lives, UK study shows


Statins not only help save lives but are great value for money too, even in lower risk patients, according…


Impax launches authorized generic of Zomig, as Mylan debuts copy of Tricor in USA


US drugmaker Impax Laboratories (Nasdaq: IPXL) says that its generics division, Global Pharmaceuticals,…

AbbVieAstraZenecaCardio-vascularGenericsImpax LaboratoriesMarkets & MarketingMylan LaboratoriesNeurologicalNorth AmericaTricorZomig

Adherence to generic cholesterol-lowering drugs linked to fall in total care costs


People who regularly take statins to reduce high cholesterol will see lower hospitalization rates according…

Cardio-vascularFinancialGenericsMarkets & MarketingNorth America

AstraZeneca in Crestor patent settlement with Actavis and EGIS Pharma


Anglo-Swedish drug major AstraZeneca (LSE: AZN) has entered into a settlement agreement in its US patent…

ActavisCardio-vascularCrestorGenericsNorth AmericaPatentsPharmaceuticalrosuvastatinShionogiWatson Pharmaceuticals

New Zealand consults on amiloride, perindopril and trandolapril funding


New Zealand's Pharmaceutical Management Agency, PHARMAC, is seeking feedback on a proposal to fund new…


Further savings expected following Australian Crestor patent decision, says GMiA


In a decision brought down by the Australian Federal Court earlier this week, suppliers of generic medicines…


Generic statins to slash global market value by 2018


The introduction of generic statins has kick-started a decline that will see the global statins market…

Cardio-vascularGenericsGlobalMarkets & Marketing

1 to 25 of 63 results

Back to top